Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects

被引：31

作者：

Kato, Masaru

Atsumi, Tatsuya ^{[1
,2
]}

机构：

[1] Hokkaido Univ, Fac Med, Dept Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan

[2] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan

来源：

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 48卷 / 02期

关键词：

connective tissue diseases; pulmonary arterial hypertension; pulmonary hypertension; systemic lupus erythematosus; systemic sclerosis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BRAIN NATRIURETIC PEPTIDE; IMMUNOSUPPRESSIVE THERAPY; VENOOCCLUSIVE DISEASE; PROGNOSTIC-FACTORS; SCLEROSIS; SURVIVAL; REGISTRY; AMBRISENTAN; PREVALENCE;

D O I：

10.1111/eci.12876

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent studies have clarified that pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH) has some distinctive clinical aspects from other PAH, such as high prevalence, venous and cardiac involvement, less favourable outcome, helpfulness of detection algorithm, response to immunosuppression, pre-PAH conditions in borderline pulmonary arterial pressure and coexistence of interstitial lung disease. In this review, by focusing on these distinctive aspects, we discuss how to provide an efficacious and safe management of CTD-PAH and garner attention to areas where further evidence is desired.

引用

页数：9

共 67 条

[1] High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis [J].

Allanore, Y. ;

Avouac, J. ;

Zerkak, D. ;

Meune, C. ;

Hachulla, E. ;

Mouthon, L. ;

Guillevin, L. ;

Meyer, O. ;

Ekindjian, O. G. ;

Weber, S. ;

Kahan, A. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (01) :284-291

[2]

[Anonymous], CHEST

[3]

ASHERSON RA, 1986, J RHEUMATOL, V13, P1

[4] Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies [J].

Avouac, Jerome ;

Airo, Paulo ;

Meune, Christophe ;

Beretta, Lorenzo ;

Dieude, Philippe ;

Caramaschi, Paola ;

Tiev, Kiet ;

Cappelli, Susanna ;

Diot, Elisabeth ;

Vacca, Alessandra ;

Cracowski, Jean-Luc ;

Sibilia, Jean ;

Kahan, Andre ;

Matucci-Cerinic, Marco ;

Allanore, Yannick .

JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) :2290-2298

[5] Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study [J].

Bonderman, Diana ;

Ghio, Stefano ;

Felix, Stephan B. ;

Ghofrani, Hossein-Ardeschir ;

Michelakis, Evangelos ;

Mitrovic, Veselin ;

Oudiz, Ronald J. ;

Boateng, Francis ;

Scalise, Andrea-Viviana ;

Roessig, Lothar ;

Semigran, Marc J. .

CIRCULATION, 2013, 128 (05) :502-U95

[6] Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry [J].

Chung, Lorinda ;

Domsic, Robyn T. ;

Lingala, Bharathi ;

Alkassab, Firas ;

Bolster, Marcy ;

Csuka, M. E. ;

Derk, Chris ;

Fischer, Aryeh ;

Frech, Tracy ;

Furst, Daniel E. ;

Gomberg-Maitland, Mardi ;

Hinchcliff, Monique ;

Hsu, Vivien ;

Hummers, Laura K. ;

Khanna, Dinesh ;

Medsger, Thomas A., Jr. ;

Molitor, Jerry A. ;

Preston, Ioana R. ;

Schiopu, Elena ;

Shapiro, Lee ;

Silver, Richard ;

Simms, Robert ;

Varga, John ;

Gordon, Jessica K. ;

Steen, Virginia D. .

ARTHRITIS CARE & RESEARCH, 2014, 66 (03) :489-495

[7] Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL Identifying Systemic Sclerosis as a Unique Phenotype [J].

Chung, Lorinda ;

Liu, Juliana ;

Parsons, Lori ;

Hassoun, Paul M. ;

McGoon, Michael ;

Badesch, David B. ;

Miller, Dave P. ;

Nicolls, Mark R. ;

Zamanian, Roham T. .

CHEST, 2010, 138 (06) :1383-1394

[8] Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study [J].

Coghlan, J. Gerry ;

Denton, Christopher P. ;

Gruenig, Ekkehard ;

Bonderman, Diana ;

Distler, Oliver ;

Khanna, Dinesh ;

Mueller-Ladner, Ulf ;

Pope, Janet E. ;

Vonk, Madelon C. ;

Doelberg, Martin ;

Chadha-Boreham, Harbajan ;

Heinzl, Harald ;

Rosenberg, Daniel M. ;

McLaughlin, Vallerie V. ;

Seibold, James R. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) :1340-1349

[9] Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial [J].

Coghlan, John Gerry ;

Galie, Nazzareno ;

Barbera, Joan Albert ;

Frost, Adaani E. ;

Ghofrani, Hossein-Ardeschir ;

Hoeper, Marius M. ;

Kuwana, Masataka ;

McLaughlin, Vallerie V. ;

Peacock, Andrew J. ;

Simonneau, Gerald ;

Vachiery, Jean-Luc ;

Blair, Christiana ;

Gillies, Hunter ;

Miller, Karen L. ;

Harris, Julia H. N. ;

Langley, Jonathan ;

Rubin, Lewis J. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) :1219-1227

[10] Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era [J].

Condliffe, Robin ;

Kiely, David G. ;

Peacock, Andrew J. ;

Corris, Paul A. ;

Gibbs, J. Simon R. ;

Vrapi, Florenc ;

Das, Clare ;

Elliot, Charlie A. ;

Johnson, Martin ;

DeSoyza, Julia ;

Torpy, Chantal ;

Goldsmith, Kim ;

Hodgkins, Denise ;

Hughes, Rodney J. ;

Pepke-Zaba, Joanna ;

Coghlan, J. Gerry .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (02) :151-157

← 1 2 3 4 5 6 7 →